35
Drugs & Behavior III: Amphetamines Brian J. Piper, Ph.D.

Introductory Psychology: Neuropharmacology III

Embed Size (px)

DESCRIPTION

lecture 9 from a college level introduction to psychology course taught Fall 2011 by Brian J. Piper, Ph.D. ([email protected]) at Willamette University, includes substituted amphetamines (methamphetamine and MDMA), epidemiology, pharmacokinetics, pharmacodynamics

Citation preview

Page 1: Introductory Psychology: Neuropharmacology III

Drugs & Behavior III: Amphetamines

Brian J. Piper, Ph.D.

Page 2: Introductory Psychology: Neuropharmacology III

Amphetamines

__

Amphetamine Methamphetamine

Page 3: Introductory Psychology: Neuropharmacology III

Amphetamines

Amphetamine Methamphetamine

___

3,4-methylenedioxymethamphetamine

Methyl: CH3; Methylene: CH2; Amine: organic compounds of Nitrogen,

Page 5: Introductory Psychology: Neuropharmacology III

Montana Meth Project• Businessman Thomas

Siebel supported graphic advertising in 2005

• Goal was to reach each teenager 3+ times/week (TV, radio, print).

To View Ads: http://www.montanameth.org/View_Ads/index.php

Page 6: Introductory Psychology: Neuropharmacology III

True of False: “the MMP results in Montana have been more significant than

any other drug prevention program in history”?

Youth Risk Behavior Survey

• High School students were asked about lifetime methamphetamine use before and after the Montana Methamphetamine Project.

Anderson (2010) J Health Econ

Page 7: Introductory Psychology: Neuropharmacology III

True or False: “the MMP results in Montana have been more significant than any other

drug prevention program in history”?

Youth Risk Behavior Survey

• High School students were asked about lifetime methamphetamine use before and after the Montana Methamphetamine Project.

Anderson (2010) J Health Econ

Page 9: Introductory Psychology: Neuropharmacology III

Robert Downey, Jr.Andre Agassi

Stacy Ann Ferguson “Fergie” Ted Arthur Haggard

Other Faces of Methamphetamine

Page 11: Introductory Psychology: Neuropharmacology III

History of EcstasyEcstasy is 3,4-methylenedioxymethamphetamine (MDMA)

• 1912: Synthesized by German pharmaceutical company Merck by Anton Kollisch (1888-1916)

• 1950’s: U.S. Army conducted animals studies to determine the lethal dose.

• 1970’s: Mental health workers advocated using MDMA with psychotherapy. There are ongoing studies to use MDMA with talk therapy for anxiety related to post-traumatic stress disorder and among terminally ill cancer patients.

• 1985: Drug Enforcement Agency (DEA) classifies MDMA as Schedule I

• 1990’s- today: MDMA is popular recreational drug, especially among young-adults.

Page 12: Introductory Psychology: Neuropharmacology III

Short-term effects of Ecstasy

• Psychological– Empathy– Increased energy– Openness– Increased sensitivity to

sounds & touch

• Physiological– Increase in heart rate– Increase in blood pressure– Reduced appetite– Bruxism: grinding teeth– Trismus: jaw clenching

Page 13: Introductory Psychology: Neuropharmacology III

Example of tolerance• Rats received ecstasy

(MDMA) on 6 days. Arrows indicate times of administration.

• Panel A shows that MDMA altered core temperature on the 1st day.

• Panel B shows that the same dose had less effects on the 3th day.

• Panel C shows almost no effects by the 6th day.

Piper et al. (2005) Developmental Psychobiology, 47, 145-157.

Page 14: Introductory Psychology: Neuropharmacology III

Amphetamines

Amphetamine Methamphetamine

___

3,4-methylenedioxymethamphetamine

Methyl: CH3; Methylene: CH2; Amine: organic compounds of Nitrogen,

Page 15: Introductory Psychology: Neuropharmacology III

Chemistry

• Entactogen: touching within (Nichols)

Amphetamine

MDA (methylenedioxyamphetamine)

MDMA (methylenedioxymethamphetamine)

Page 16: Introductory Psychology: Neuropharmacology III

Ecstasy = MDMA?

Page 17: Introductory Psychology: Neuropharmacology III

Drug Levels in the Blood: Individual Differences Following Oral Administration of MDMA

Plasma MDMA for each marmoset thatreceived 1 mg/kg.

0 20 40 600

10

20

30

40

50

60

70

80

Eric

Autumn

Lexi

Zale

Time

MD

MA

(n

g/m

l)

Ng/ml

Page 18: Introductory Psychology: Neuropharmacology III

Age Influences How Your Body Responds to Drugs

MDMA -----> MDA

Meyer, Piper,& Vancolli (2010) Annals of the New York Academy of Sciences.

Page 19: Introductory Psychology: Neuropharmacology III

Brain Chemistry

• MDMA increases neurotransmitters (serotonin, norepinephrine, dopamine) & hormones (cortisol, prolactin)

Page 20: Introductory Psychology: Neuropharmacology III

Serotonin

• Serotonin is 5-hydroxytryptamine (5-HT)• The brain uses the amino acid tryptophan

(found in bananas, milk, yogurt) to make 5-HT.• 5-HT has been implicated in mood (anxiety,

depression & aggression), appetite, sexuality, and cognition.

See also: http://en.wikipedia.org/wiki/Serotonin

Page 21: Introductory Psychology: Neuropharmacology III

Raphe nuclei

• 5-HT cell bodies (somas) are found in the brainstem in the raphe nuclei.

• 5-HT axons descend into spinal cord and ascend to the hippocampus and cortex.

Page 22: Introductory Psychology: Neuropharmacology III

Serotonin Transporter (SERT)• SERT is a protein found at the synapse and

along the axon that removes 5-HT from the synaptic cleft.

• SERT (shown in pink) brings 5-HT from the synaptic cleft back into the axon.

• Serotonin reuptake inhibitors (e.g. Prozac or fluoxetine) prevent SERT from removing 5-HT.

• The density of SERT is used as a index of the number of 5-HT axons and is altered by MDMA.

Page 23: Introductory Psychology: Neuropharmacology III

Long-term effects of High Dose MDMA on 5-HT neurons (animal data)

• Weeks after MDMA treatment to animals, there is a reduction in 5-HT, 5-HT metabolites, and SERT which suggests a 5-HT axotomy (axons are cut).

• Months to years after MDMA in monkeys, some brain areas still show a reduction in SERT and 5-HT (hypoinnervation). However, other areas show an abnormal increase in SERT and 5-HT (hyperinnervation).

Page 24: Introductory Psychology: Neuropharmacology III

Serotonin fibers in the caudate nucleus of a control squirrel monkey (A), a monkey that received 5 mg/kg MDMA 2 weeks (B),

or 7 years (C) previously.

Hatzidimitriou, G. et al. J. Neurosci. 1999;19:5096-5107

Page 25: Introductory Psychology: Neuropharmacology III

What about brain function?

• Complex behaviors can be measured in non-human animals like:– Attention– Learning– Memory– “Emotion”

Page 26: Introductory Psychology: Neuropharmacology III

Object-Recognition Memory Task

Rats were exposed to two identicalobjects in a 3-min sample phase.

There was a retention delay (15 min),during which both objects were replaced:one replacement object was identical to theprevious two, while the other was a novelobject.

Memory of the familiar object isindicated by the animal spending moretime exploring the novel object during a3-min choice phase.

Figure from A. Ennaceur.

Page 27: Introductory Psychology: Neuropharmacology III

Adolescent MDMA decreases memory.

Saline MDMA

Sample (A) 25.6 (3.1) 23.5 (1.4)

Test (A) 11.8 (2.0) 14.9 (1.4)

Test (B) 24.7 (3.5) 20.0 (3.1)

B/(A+B) 0.68 (0.03) 0.56 (0.04)*

Piper & Meyer (2004) Pharm Biochem & Behav 79: 723-731

Page 28: Introductory Psychology: Neuropharmacology III

Adolescent MDMA reduces anxiety-like

behavior.

BEHAVIORSALINE-

TREATEDMDMA-

TREATEDP VALUE

Total arm entries 19.1 ± 3.0 27.4 ± 3.0 .074

Open-arm entries 3.1 ± 1.4 7.9 ± 1.8 .058

Open/Total (%) 12.8 ± 5.2 27.3 ± 5.3 .071

Open-arm duration (sec)

41.4 ± 18.7 108.9 ± 20.3 <.05

Closed-arm duration (sec)

507.4 ± 30.5 400.5 ± 30.3 <.05

Piper & Meyer (2004) Pharm Biochem & Behav 79: 723-731.

Page 29: Introductory Psychology: Neuropharmacology III

Piper & Meyer (2004) Pharm Biochem & Behav 79: 723-731.

Page 30: Introductory Psychology: Neuropharmacology III

Spatial Memory In Rodents• Rodent research has found that early developmental

Methamphetamine treatments cause persistent impairments in spatial memory.

Acevedo SF, de Esch IJ, Raber J (2007) Neuropsychopharmacology 32:665-672

Page 31: Introductory Psychology: Neuropharmacology III

MDMA Summary

• Short-Term Effects: – Empathy– hyperthermia, – ↑5-HT & Dopamine

• Long-Term Effects: ↓5-HT

Page 32: Introductory Psychology: Neuropharmacology III

Amphetamine Comparison

MDMA Methamphetamine

History One-century One-century

Acute Subjective Effects Empathy Euphoria

Neurotoxicity Serotonin Dopamine

Schedule I III

Addiction No Yes

Page 33: Introductory Psychology: Neuropharmacology III

Hallucinogens

Hallucinogens are psychedelic (mind-manifesting) drugs

that distort perceptions and evoke sensory images in the

absence of sensory input.

Ronald K

. Siegel

Page 34: Introductory Psychology: Neuropharmacology III

Hallucinogens

1. LSD: (lysergic acid diethylamide) powerful hallucinogenic drug that is also known as acid.

2. THC (delta-9-tetrahydrocannabinol): is the major active ingredient in marijuana (hemp plant) that triggers a variety of effects, including mild hallucinations.

http://static.how

stuffworks.com

Hemp Plant

Page 35: Introductory Psychology: Neuropharmacology III

DrugsSummary